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Near‑infrared spectroscopy 
of blood plasma with chemometrics 
towards HIV discrimination 
during pregnancy
Daniel L. D. Freitas1, Ana F. S. Peres2,3, Lidiane G. Silva1, João V. M. Mariz1, 
Marcos G. Santos2,4, Rayanne S. P. Morais3, Camilo L. M. Morais5, Francis L. Martin6, 
Daniel A. V. Pascoal2, Juliana D. de A. S. Camargo2, Janaina C. O. Crispim2,3 & 
Kassio M. G. Lima1,7*
Prevention of mother‑to‑child transmission programs have been one of the hallmarks of success in 
the fight against HIV/AIDS. In Brazil, access to antiretroviral therapy (ART) during pregnancy has 
increased, leading to a reduction in new infections among children. Currently, lifelong ART is available 
to all pregnant, however yet challenges remain in eliminating mother‑to‑child transmission. In this 
paper, we focus on the role of near‑infrared (NIR) spectroscopy to analyse blood plasma samples of 
pregnant women with HIV infection to differentiate pregnant women without HIV infection. Seventy‑
seven samples (39 HIV‑infected patient and 38 healthy control samples) were analysed. Multivariate 
classification of resultant NIR spectra facilitated diagnostic segregation of both sample categories in 
a fast and non‑destructive fashion, generating good accuracy, sensitivity and specificity. This method 
is simple and low‑cost, and can be easily adapted to point‑of‑care screening, which can be essential 
to monitor pregnancy risks in remote locations or in the developing world. Therefore, it opens a new 
perspective to investigate vertical transmission (VT). The approach described here, can be useful for 
the identification and exploration of VT under various pathophysiological conditions of maternal 
HIV. These findings demonstrate, for the first time, the potential of NIR spectroscopy combined with 
multivariate analysis as a screening tool for fast and low‑cost HIV detection.
HIV has many routes of transmission including from mother-to-child, which its called vertical transmission 
(VT). Worldwide, the World Health Organization (WHO) has estimated that some 1.3 million pregnant women 
are infected with  HIV1, while in Brazil, 125,144 cases have been diagnosed between 2000 and 2019, accord-
ing to the epidemiologic bulletin of the Brazil’s Health  Ministry2. Among the pregnant women carrying HIV, 
15–45% will transmit the virus to their child if diagnosis and adequate treatment are not  employed3. This form 
of infectivity has great relevance and requires a great degree of attention from health organizations due to its 
undesirable consequences to the mother or child, such as abortion, stillbirth, neonatal death, premature birth, 
low birth weight, amongst  others4.
Early diagnosis and treatment with antiretrovirals are measures that exhibit great potential towards reducing 
vertical transmission to < 5%3. Therefore, public health organizations are constantly pushing for more diagnosis, 
with an increase of 21% in the number of prenatal diagnoses in the last 10  years5. However, studies indicate that 
in Brazil only around 15% of pregnant women fully comply with their prenatal appointments schedule and 
necessary exams.
The development of a novel tools for the diagnosis of different diseases is extremely important, mostly when 
they affect pregnant women, as it is the case in which VT is capable of harming both mother and the fetus. New 
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methodologies based on spectrometric techniques are an alternative for metabolomic screening of biofluids. Mass 
spectrometry and nuclear magnetic resonance (NMR) are the most common spectrometric techniques due to 
their relatively good sensitivity and specificity to detect diseases, although they carry an elevated cost and require 
a complex experimental  setup6. Near-infrared (NIR) spectroscopy is a spectrometric technique that explores 
high-energy vibrational modes of molecular chemical bonds, generating a sample spectrochemical spectrum 
in the region between 750 to 2500  nm7–9. This technique employs relatively simple and low-cost instrumenta-
tion when compared to mass spectrometry, NMR or even mid-infrared spectroscopy, and is widely available 
in portable handheld devices for in-field analysis. In addition to the simple instrumentation, this technique is 
non-destructive and also reagent-free, thus experimental measurements can be performed quickly and with no 
or minimal sample preparation.
Therefore, there is a need for accurate and low-cost techniques for VT detection. NIR together with chemo-
metric methods has played an increasingly important role in the field of medical and biological analysis, through 
quickly detecting pathological conditions, even at very early stages. Previous studies have demonstrated the 
clinical applications of using NIR spectroscopy in biological samples such as to detect Alzheimer’s disease in 
blood plasma with 93% of accuracy, 88% of sensibility and 96% of  specificity9; to differentiate strains of Kleb-
siella pneumonia producing and non-producing  carbapenemase10; and for the identification of Aedes aegypti 
mosquitoes infected by the Zika  virus11. It was also used with HIV, however, with others goals that were not the 
discrimination between infected and healthy  groups7.
A previous study of our group showed that it was possible to differentiate groups of pregnant women liv-
ing with HIV from those who were not infected by the virus using the ATR-FTIR technique (Attenuated Total 
Reflection Fourier-Transform Infrared spectroscopy)12. Herein, NIR spectroscopy is employed to distinguish 
HIV-infected pregnant women compared to healthy pregnant controls (without co-morbidities). Towards this, 
different chemometric techniques of multivariate classification were tested with the spectral dataset in order to 
optimize diagnostic results. In this study, our aim was to utilize NIR to differentiate groups of pregnant women 
with HIV from pregnant women without it.
Results
Statistical analysis of clinical data. Demographic and epidemiological data of the participants can be 
observed in Table 1.
There was a significant association between the HIV diagnosis and the level of schooling, χ2 (1) = 4.715, 
p < 0.05. The proportion of pregnant women with education level no higher than middle school was superior in 
the HIV group (69.2%) when compared with the control group (44.7%) (Table 1).
Table 1.  Patients characteristics. OR odds ratio, TI trust interval. Significance p < 0.05 are highlighted in bold. 
Abortions, n (%)in bold.
Variables
Group
p  valuea Total OR (TI 95%)Living with HIV Healthy pregnant
N, % 39 (50.6) 38 (49.4) 77 (100.0)
Age, years 29 ± 6 31 ± 6 0.085 30 ± 6 –
Education, n (%)
Middle school 27 (69.2) 17 (44.7) 0.030 44 (57.1) 2.78 (1.09–7.07)
High school or superior 12 (30.8) 21 (55.3) 33 (42.9) Ref.
Current smoking, n (%)
Yes 3 (7.7) 0 (0.0) 0.240 3 (3.9) –
No 36 (92.3) 38 (100.0) 74 (96.1) –
History of smoke, n (%)
Yes 14 (35.9) 15 (39.5) 0.746 29 (37.7) 0.86 (0.34–2.16)
No 25 (64.1) 23 (60.5) 48 (62.3) Ref
Drug use, n (%)
Yes 10 (25.6) 3 (7.9) 0.038 13 (16.9) 4.02 (1.01–16.00)
No 29 (74.4) 35 (92.1) 64 (83.1) Ref.
Gestacional age, weeks 22 ± 7 24 ± 7 0.262 23 ± 7 –
Pregnancies, n (%)
More ore qual to 4 pregnancies 12 (30.8) 9 (23.7) 0.485 21 (27.3) 1.43 (0.52–3.94)
Until 3 pregnancies 27 (69.2) 29 (76.3) 56 (72.7) Ref.
Births, n (%)
None 10 (25.6) 7 (18.4) 0.445 17 (22.1) 1.53 (0.51–4.55)
One or more births 29 (74.4) 31 (81.6) 60 (77.9) Ref.
(%)
One or more abortions 12 (30.8) 8 (21.1) 0.331 20 (26.0) 1.67 (0.59–4.69)
None 27 (69.2) 30 (78.9) 57 (74.0) Ref.
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The patients with education level until middle school had a chance 2.78 times higher of having HIV (OR = 2.78; 
IC95%: 1.09–7.07) when compared to the patients who completed high school or a superior degree (Table 1).
There was a significant association between the HIV diagnosis and the use of drugs, χ2 (1) = 4.319, p < 0.05. 
The proportion of pregnant women that use drugs was superior in the HIV group (25.6%) when compared to 
the control group (7.9%) (Table 1).
The patients who use drugs had a chance approximately 4 times higher of having HIV (OR = 4.02; IC95%: 
1.01–16.00) when compared to the patients who don’t use drugs (Table 1). No significant association was 
observed between the CD4+/CD8+ ratio and the maximum viral load (ρ = − 0.346, p = 0.206). Furthermore, the 
CD4+ cell count showed a negative correlation with the maximum viral load (ρ = − 0.642, p = 0.010).
NIR spectroscopy. NIR spectroscopy is a valuable tool capable of analysing different types of diseases by 
measuring biologically-derived samples. Herein, NIR spectroscopy was employed to detect HIV-infected blood 
plasma samples spectra of pregnant patients, where metrics such as diagnostic accuracy, sensitivity and speci-
ficity were calculated. Seventy-seven blood plasma samples were analysed, with 39 samples originating from 
HIV-infected pregnant women and 38 from healthy pregnant controls. Three spectra were collected per sample, 
resulting in a total of 231 spectra. The spectra were cut in the region between 1850 to 2150 nm, responsible 
for biomolecular-derived spectrochemical signatures. The average raw spectrum for each group of sample is 
depicted in Fig. 1A. To reduce noise, the raw spectral data were pre-processed by Savitzky–Golay (SG) smooth-
ing and baseline correction (Fig. 1B). There is a high degree of superposition between spectral features among 
categories; consequently, multivariate analysis tools are necessary to distinguish the categories.
The spectral data were divided into training (70%) and test (30%) sets using the Kennard–Stone (KS) sample 
selection algorithm. To predict whether pregnant women are affected by HIV, it is necessary to use supervised 
classification models capable of extracting spectral features that differentiate the HIV-infected pregnant category 
spectra from those of healthy pregnant controls. Several supervised classification techniques were tested to 
discriminate the data; their performances are depicted in Table 2.
The best discrimination results were found for GA-QDA (accuracy of 87%), followed by GA-LDA (accuracy 
of 83%). The GA-LDA model selected 3 variables for category discrimination: 1929 nm, 1932 nm and 2151 nm 
(Fig. 2A); with a discriminant function plot showing 4 samples misclassified in the test set (Fig. 2B). GA-QDA 
Figure 1.  Average NIR spectra. (A) Raw spectra; (B) pre-processed (SG smoothing and baseline correction) 
spectra for the HIV-infected pregnant group (HIV) and healthy pregnant controls (Control).
Table 2.  Quality parameters calculated for the test set using different supervised classification algorithms to 
distinguish HIV-infected pregnant women and healthy pregnant controls. AC accuracy in %, SENS sensitivity 
in %, SPEC specificity in %. The best algorithm (GA-QDA) is highlighted in bold.
Model AC (%) SENS (%) SPEC (%)
PCA-LDA 74 83 64
PCA-QDA 70 92 46
PCA-SVM 74 83 64
SPA-LDA 74 83 64
SPA-QDA 78 83 73
SPA-SVM 78 83 73
GA-LDA 83 83 82
GA-QDA 87 83 91
GA-SVM 74 75 73
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also selected the same 3 variables (Fig. 2C), but with a more powerful discriminant function whereby 3 samples 
are misclassified in the test set (Fig. 2D). Three spectral wavelengths were responsible for class separation based 
on GA-LDA/QDA (1929, 1932 and 2151 nm).
The QDA algorithm performs better than LDA when categories have different covariance structures, since 
LDA assumes the categories having similar covariance matrices; hence, using a pooled covariance matrix for cal-
culation, while QDA models each category covariance matrix  separately13. Thus, GA-QDA is the best algorithm 
considering the analysis of complex sample matrices with different internal variances. The first two variables 
selected by GA-QDA (1929 and 1932 nm) are related to OH stretching in carbohydrates, while the variable at 
2151 relates to C=O and C–N stretching in  proteins14,15.
Discussion
There are few studies that relate HIV and the search for new tools that will predict the possible diagnosis of HIV. 
To our knowledge, our group was first to use the Near-infrared spectroscopy with multivariate classification to 
analyze the blood plasma collected from pregnant women with HIV, where we observed towards HIV discrimi-
nation during pregnancy. In a previous study, our group found a similar result using the ATR-FTIR technique, 
where we were able to discriminate the groups with and without  HIV12.
In this study, 77 blood plasma samples taken from pregnant women were analysed using NIR spectroscopy 
to detect HIV-infected patients. Different chemometric algorithms were tested for category discrimination, but 
the best classification performance was obtained with GA-QDA. HIV-infected samples were discriminated from 
the healthy control category with 87% accuracy, 83% sensitivity and 91% specificity using 3 spectral wavelengths 
selected by the genetic algorithm: 1929, 1932 and 2151 nm. The absorbances at 1929 nm and 1932 nm represent 
OH stretching of carbohydrates and the absorbance at 2151 nm the C=O and C–N stretching of  proteins14,16.
According to the variables selected by the GA, we can imply that there was a slightly difference in the pro-
teins and carbohydrates content between the tested groups. As known, blood plasma is mainly composed of 
water; however, there is a small proportion of proteins (albumin, fibrinogen and immunoglobulins), metabolites, 
carbohydrates, lipids, among other  molecules6. This composition normally has pre-establish reference values, 
however, infections can generate metabolic chances that alter these values.
Figure 2.  GA-LDA and GA-QDA results. (A) Selected variables by GA-LDA; (B) discriminant function in the 
test set for GA-LDA; (C) selected variables by GA-QDA; (D) discriminant function in the test set for GA-QDA. 
HIV HIV-infected pregnant group, Control healthy pregnant controls.
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Among the variables selected by GA-QDA, overall the absorbance at 2151 nm (proteins) was found to be 
slightly higher in the HIV-infected category. Despite the metabolic alterations caused by virus infections, in this 
case by HIV, are not yet well understood in literature, it can be assumed that the increase of proteins in the HIV-
infected samples are due to the direct action of the virus in the cell, where hyperactivation of the immunologic 
system caused by the HIV generates more immunoglobulins to fight the  infection17.
The NIR spectroscopy is an analytical technique with small chemical specificity due to the high degree of 
overlapping of many spectral features; thus, pure biomarker identification solely based on this technique is not 
feasible. Although we managed to separate the groups successfully, further studies are necessary to generate a 
spectral pattern that is characteristic of patients with HIV. Thus, new tests with patients that are not pregnant 
are not in antiretroviral therapy and patients with other viral infections are very important to the validation of 
the technique as a possible diagnostic tool.
Methods
Design of study and population. This is a nested case–control study that was conducted in a Reference 
Obstetrics Center for AIDS at the School Maternity Januario Cicco (MEJC), located in Natal, Rio Grande do 
Norte, Brazil, between March 2017 and May 2019. A total of 39 pregnant women living with HIV were recruited, 
all a single pregnancy and gestational age between 10 and 38 weeks. The patients were selected spontaneously 
during their prenatal care at the Infectious Diseases Clinic at this reference maternity. All pregnant women living 
with HIV were monitored by an infectologist and an obstetrician. Only participants with complete clinical infor-
mation were included in the analysis. Subjects were excluded if they had chronic medical conditions, including 
hypertension, type 2 diabetes mellitus, or heart or kidney diseases.
The study was approved by the Ethics Committee of the Federal University of Rio Grande do Norte under 
the protocol number 1.808.891. Written informed consent was obtained from every participant. All procedures 
were performed in compliance with the Declaration of Helsinki.
Clinical measurements. Clinical data were collected by medical record review. Women living with HIV 
were categorized according to Antiretroviral Therapy (ART) exposure during their prenatal follow-up. Clinical, 
socio-epidemiological and laboratorial characteristics were summarized and submitted to a statistical analysis. 
We examined counts of CD4 cells, CD8 cells and CD4/CD8 ratios that are summarized in Table 3.
Healthy pregnant control group. This study includes 38 healthy pregnant women who attended a low-
risk maternity hospital. The pregnant women were between 19 and 44 years old with a gestational age between 
10 and 38 weeks. All were HIV negative and did not present with any other co-morbidity.
Blood plasma analysis by NIR. A blood sample from each patient was collected in EDTA tubes and then 
submitted to centrifugation for 10 min at 1500 rpm at room temperature to obtain blood plasma for subsequent 
spectroscopic analysis. Maternal serum samples were collected at the time of clinically indicated blood tests and 
store at − 80 °C for research purpose.
NIR spectroscopy. Plasma aliquots (stored frozen) were left to thaw for several minutes at room tempera-
ture before spectrochemical measurement. Measurements were performed in a random order without the ana-
lyst having a prior knowledge of the samples’ category. An equal number of samples were analysed per day. 
Before analysis, the plasma samples were homogenised for 1 min in a portable vortex mixer (Gilson Inc., USA), 
and then 25 μL of plasma were collected for each sample using a micropipette. The 25 μL plasma volume was 
then transferred to a clean enzyme-linked immunosorbent assay (ELISA) microplate (96 wells, U-type bottom). 
Spectrochemical measurements were carried out using an ARCoptix FT-NIR Rocket spectrometer (ARCoptix 
S.A., Switzerland) in the 900–2600 nm range using a fibre optic positioned onto each ELISA microwell in trans-
flectance mode. Three replica spectra were collected per sample using an ambient air spectrum as background.
Computational analysis. The spectral data were organized in a matrix form, where the rows contained the 
sample spectrum and columns contained the spectral variables (absorbance intensities for each wavelength). The 
Table 3.  Clinical variables of the pregnant patients infected with HIV (n = 39). The categorical data are 
expressed by absolute (n) and relative (%) frequencies. The continuous data are expressed by median and 
percentiles 25 and 75 and by mean and standard deviation.
Variables HIV group
Viral load, n (%)
Undetectable 21 (53.8)
Detectable 15 (38.5)
No information 3 (7.7)
Viral load,  mm8 3.423 (311–8.885)
CD4+, cells (n = 36) 447 (328–804)
CD8+, cells (n = 36) 715 ± 272
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data were processed using MATLAB R2014b environment (MathWorks Inc., USA) using PLS Toolbox version 
7.9.3 (Eigenvector Research Inc., USA) and lab-made routines.
For supervised classification, the samples’ spectra were divided into training (70%, n = 54 [27 HIV-infected, 
27 healthy controls]) and test sets (30%, n = 23 [12 HIV-infected, 11 healthy controls]) using the Kennard–Stone 
(KS)  algorithm18. The training set is used for model construction and the test set for model validation. The 
models were built by combining feature extraction/selection algorithms with discriminant analysis. Principal 
component analysis (PCA)19 was used for feature extraction, while successive projections algorithm (SPA)20 
and genetic algorithm (GA)21 were used for feature selection. Discriminant analysis was performed by linear 
discriminant analysis (LDA) and quadratic discriminant analysis (QDA) combined with PCA (PCA-LDA/QDA), 
SPA (SPA-LDA/QDA) and GA (GA-LDA/QDA). These algorithms were tested independently in order to find 
the best classification model.
For PCA-LDA/QDA, the PCA scores are used as input variables for LDA or  QDA13. In SPA-LDA/QDA or 
GA-LDA/QDA, the selected variables by SPA or GA are used as input variables for LDA or  QDA22. The spectral 
variables are selected in SPA and GA by minimising the cost function G according to the following equation:
where NV represents the number of validation samples and gn is calculated as follows:
where r2(xn, mI(n)) is the squared Mahalanobis distance between the object  xn and the centre of its true category 
mI(n) ; and r2(Xn, mI(m)) is the squared Mahalanobis distance between the object xn and the centre of the closest 
wrong category mI(m) . GA was performed using 100 generations with 200 chromosomes each; and the mutation 
and cross-over probabilities were set at 10% and 60%, respectively.
The LDA ( Lik ) and QDA ( Qik ) classification scores are calculated in a non-Bayesian form as  follows13,23:
where  xi is a vector containing the input variables for sample i; xk is the mean spectrum of category k; Cpooled is 
the pooled covariance matrix; and  Ck is the variance–covariance matrix for category k.
Model validation. The models validation performances were evaluated by calculating the accuracy (AC), 
sensitivity (SENS) and specificity (SPEC) for the test set. AC represents the total number of samples correctly 
classified; SENS represents the proportion of positives correctly classified; and SPEC represents the proportion 
of negatives correctly classified. These parameters are calculated as  follows24:
where AC stands for accuracy, SENS for sensitivity, SPEC for specificity, TP for true positives, TN for true nega-
tives, FP for false positives, and FN for false negatives.
Statistical analysis. Descriptive analyses were conducted on the sociodemographic, clinical and biologi-
cal data of the participants. For each categorical and continuous variable, data are reported as proportions or 
mean (with standard deviation) or median with interquartile range (IQR) respectively. Shapiro–Wilk normality 
test was applied to verify the adherence of the continuous variables to the normal distribution. A descriptive 
analysis of the adherent variables to the normal distribution was performed by mean and standard deviation 
(mean ± SD). The analysis was realized through absolute and relative frequencies to the categorical variables. 
The Student t test to independent samples was applied to the continuous variables that showed normality. The 
Chi-Square test was used to analyze the association between the HIV diagnosis and the categorical variables. In 
case of expected frequencies below five, it was applied the Fisher exact test. The odds ratio with trust interval of 
95% was calculated to the binary categorical variables. The Spearman correlation was executed to evaluate the 
association between the CD4+/CD8+ ratio to the variables CD4+, CD8+ and the maximum viral load. The same 
correlation was also executed to associate the CD4+ cell count to the maximum viral load. The significance level 
of 5% was adopted to all the analysis.










(3)Lik = (xi − xk)TC−1pooled(xi − xk)
(4)Qik = (xi − xk)TC−1k (xi − xk)
(5)AC (%) = [(TP+ TN)/(TP+ FP+ TN+ FN)]× 100
(6)SENS (%) = [TP/(TP+ FN)]× 100
(7)SPEC (%) = [TN/(TN+ FP)]× 100
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